BioCentury
ARTICLE | Company News

Regulus, Sanofi deal

February 10, 2014 8:00 AM UTC

Sanofi and Regulus extended a 2010 deal to discover, develop and commercialize microRNA therapeutics to treat Orphan indications and cancer. Under the extension, Regulus granted Sanofi an exclusive op...